Location History:
- Gaitherburg, MD (US) (2017)
- Gaithersburg, MD (US) (2014 - 2020)
Company Filing History:
37 out of 47 
4 out of 63 
1 out of 216 
Years Active: 2014-2020
Areas of Expertise:
Title: Todd Hembrough: A Visionary Innovator Pushing Boundaries in Technology
Introduction:
Throughout his career, Todd Hembrough has established a remarkable track record of achievements and gained recognition for his groundbreaking work in the field of technology. With a steadfast dedication to innovation, Todd has been honored with various awards and invitations to speak at prestigious conferences and events. His latest patents, relating to cancer treatment and diagnostic methods, highlight his ongoing commitment to advancing the medical field.
Latest Patents:
Todd Hembrough's recent patents demonstrate his role in developing cutting-edge strategies for cancer treatment. The first patent, titled "Predicting optimal chemotherapy for CRC," focuses on identifying the responsiveness of cancer patients, particularly those with colorectal cancer, to treatment with the FOLFOX regimen (5-fluorouracil, leucovorin, and oxaliplatin). By detecting and quantifying specific TYMP and UCK2 fragment peptides through SRM-mass spectrometry, these methods enable the determination of patient response to the combination treatment.
The second patent, "OPRT expression and cancer treatment outcome," offers improved methods for treating cancer, particularly colon and gastric cancers. By measuring the OPRT, TYMP, and/or UCK2 proteins in tissue samples from patients, the diagnostic methods provided allow for the prediction of patient response to the FOLFOX regimen or a combination of capecitabine and cisplatin.
Career Highlights:
Todd Hembrough has enjoyed a successful career marked by significant contributions. With a total of 42 patents to his name, he consistently demonstrates his commitment to pioneering advancements in the field of technology. Todd's work has earned him numerous accolades, highlighting his dedication to pushing the boundaries of innovation.
Collaborations:
Throughout his journey, Todd has collaborated with esteemed colleagues in companies such as Expression Pathology Incorporated and Nantomics, LLC. These collaborations have allowed for the exchange of ideas and expertise, fostering an environment of innovation and driving forward progress in the field.
Conclusion:
Todd Hembrough's remarkable career reflects his status as a visionary innovator in the technology industry. Through his numerous patents and dedication to pushing the boundaries of possibility, he has made substantial contributions to the field of cancer treatment and diagnostics. As an influential figure in his field, Todd continues to shape the future of technology through his groundbreaking work.